In this issue:
Insulin pumps vs. MDIs with structured education in type 1 diabetes
Liraglutide for reducing progression risk in prediabetes
Basal-bolus fast-acting insulin aspart for type 1 diabetes
Basal-bolus fast-acting insulin aspart for type 2 diabetes
Nocturnal glycaemia with insulin analogues vs. human insulin
ADA recommendations for pharmacological type 2 diabetes treatment
Screening frequency for retinopathy in type 1 diabetes
Mortality and CV disease in types 1 and 2 diabetes
Birth season affects type 2 diabetes risk in adulthood
Gestational diabetes and adverse perinatal outcomes
Please login below to download this issue (PDF)